New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"

New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvizi, Nassim, Parvizi, Sahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726322/
https://www.ncbi.nlm.nih.gov/pubmed/29172379
http://dx.doi.org/10.15171/ijhpm.2017.59
_version_ 1783285701537693696
author Parvizi, Nassim
Parvizi, Sahar
author_facet Parvizi, Nassim
Parvizi, Sahar
author_sort Parvizi, Nassim
collection PubMed
description New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom.
format Online
Article
Text
id pubmed-5726322
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-57263222017-12-18 New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies" Parvizi, Nassim Parvizi, Sahar Int J Health Policy Manag Commentary New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom. Kerman University of Medical Sciences 2017-05-09 /pmc/articles/PMC5726322/ /pubmed/29172379 http://dx.doi.org/10.15171/ijhpm.2017.59 Text en © 2017 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Parvizi, Nassim
Parvizi, Sahar
New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
title New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
title_full New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
title_fullStr New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
title_full_unstemmed New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
title_short New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
title_sort new health technologies: a uk perspective: comment on "providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies"
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726322/
https://www.ncbi.nlm.nih.gov/pubmed/29172379
http://dx.doi.org/10.15171/ijhpm.2017.59
work_keys_str_mv AT parvizinassim newhealthtechnologiesaukperspectivecommentonprovidingvaluetonewhealthtechnologytheearlycontributionofentrepreneursinvestorsandregulatoryagencies
AT parvizisahar newhealthtechnologiesaukperspectivecommentonprovidingvaluetonewhealthtechnologytheearlycontributionofentrepreneursinvestorsandregulatoryagencies

Ejemplares similares